Number-needed-to-treat (NNT)--needs treatment with care
- PMID: 16867164
- DOI: 10.1111/j.1742-7843.2006.pto_412.x
Number-needed-to-treat (NNT)--needs treatment with care
Abstract
The "number-needed-to-treat" (NNT) was introduced about 15 years ago and has gained widespread use. It has been claimed to be "easy to understand" and gives "intuitive meaning". When used to measure the effectiveness of interventions targeting chronic disease processes e.g. atherosclerosis and osteoporosis, NNT (as well as relative and absolute risk reduction) does not capture the crucial time component, a fact that has important consequences: NNT varies over time, it may not mean that adverse events (fractures, myocardial infarctions etc.) are avoided, but simply that they are postponed. Finally, empirical studies indicate that lay people and doctors misunderstand NNT. We recommend that NNT be used with considerable care. There is probably no single effect measure that is able to convey all necessary information.
Similar articles
-
Annualized was found better than absolute risk reduction in the calculation of number needed to treat in chronic conditions.J Clin Epidemiol. 2006 Mar;59(3):217-23. doi: 10.1016/j.jclinepi.2005.07.006. Epub 2005 Oct 13. J Clin Epidemiol. 2006. PMID: 16488351 Review.
-
[Number needed to treat (NNT)-- misleading, misunderstood, misused?].Tidsskr Nor Laegeforen. 2004 Aug 12;124(15):1926-9. Tidsskr Nor Laegeforen. 2004. PMID: 15306861 Norwegian.
-
Evidence-based dermatology: number needed to treat and its relation to other risk measures.J Am Acad Dermatol. 2007 Apr;56(4):664-71. doi: 10.1016/j.jaad.2006.08.024. Epub 2006 Oct 27. J Am Acad Dermatol. 2007. PMID: 17367615 Review.
-
Evidence-based evaluation of benefits in therapeutic interventions: methodologically controlled and non-randomly assigned reflections on the number needed to treat.Ital Heart J. 2003 Feb;4(2):80-3. Ital Heart J. 2003. PMID: 12762269 Review.
-
Cost-effectiveness analysis based on the number-needed-to-treat: common sense or non-sense?Health Econ. 2004 Jan;13(1):9-19. doi: 10.1002/hec.797. Health Econ. 2004. PMID: 14724890
Cited by
-
Communicating effectiveness of intervention for chronic diseases: what single format can replace comprehensive information?BMC Med Inform Decis Mak. 2008 Jun 19;8:25. doi: 10.1186/1472-6947-8-25. BMC Med Inform Decis Mak. 2008. PMID: 18565218 Free PMC article. Clinical Trial.
-
Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trial.RMD Open. 2016 Sep 28;2(2):e000308. doi: 10.1136/rmdopen-2016-000308. eCollection 2016. RMD Open. 2016. PMID: 27752357 Free PMC article.
-
An Evidence-Based Medicine Approach to Antihyperglycemic Therapy in Diabetes Mellitus to Overcome Overtreatment.Circulation. 2017 Jan 10;135(2):180-195. doi: 10.1161/CIRCULATIONAHA.116.022622. Circulation. 2017. PMID: 28069712 Free PMC article. Review.
-
The effect of statins on average survival in randomised trials, an analysis of end point postponement.BMJ Open. 2015 Sep 24;5(9):e007118. doi: 10.1136/bmjopen-2014-007118. BMJ Open. 2015. PMID: 26408281 Free PMC article.
-
The "number needed to treat" turns 20--and continues to be used and misused.CMAJ. 2008 Sep 9;179(6):549-53. doi: 10.1503/cmaj.080484. CMAJ. 2008. PMID: 18779528 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources